Pioglitazone Hydrochloride

Product NDC
72606-570
11-digit product format
726060570
Labeler code
72606
Product ID
72606-570_7d46fdfa-22fd-4711-a7b1-bb0aab912357
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pioglitazone Hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
CELLTRION USA, INC.
Application
ANDA076798
Marketing category
ANDA
Marketing start
2020-10-28
Marketing end
0000-00-00
Substance
PIOGLITAZONE HYDROCHLORIDE
Active strength
15 mg/1
Pharmacologic classes
Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72606-570-01EA - Each72606-570ed124117-97d4-45b3-a306-6047ebb488a012021-03-02
72606-570-02EA - Each72606-57046c44a1f-4e7b-4ba2-ab4c-87c545e40e5012021-03-02
72606-570-03EA - Each72606-5707a947544-448f-42a7-9d1a-5541d75802b512021-03-02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
72606-570-017260605700130 TABLET in 1 BOTTLE (72606-570-01) 30 tablet2020-10-280000-00-00NoNoCurrent
72606-570-027260605700290 TABLET in 1 BOTTLE (72606-570-02) 90 tablet2020-10-280000-00-00NoNoCurrent
72606-570-0372606057003500 TABLET in 1 BOTTLE (72606-570-03) 500 tablet2020-10-280000-00-00NoNoCurrent